A brain molecule has been found to reverse movement deficits in Parkinson’s, presenting a new potential therapeutic target. A research team from the University of California, Irvine is the first to reveal that a molecule in the brain – ophthalmic acid – unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering […]
